Abstract:Journal of Dental Research, Ahead of Print. Small nucleolar RNAs (snoRNAs), a distinct class of noncoding RNAs, encompass highly diverse structures and have a range of 60 to 300 nucleotides in length. About 90% of human snoRNAs are intronic and embedded within introns of their host gene transcripts. Most snoRNAs enriched in specific tissue correlate in abundance with their parental host genes. Advancements in high-throughput sequencing have facilitated the discovery of dysregulated snoRNA expression in numerous human malignancies including head and neck squamous cell carcinoma (HNSCC). Hundreds of differentially expressed snoRNAs have been identified in HNSCC tissues. Among 1,524 snoRNA genes in a 567 HNSCC cohort, 113 snoRNAs were found to be survival related. As for snoRNA's roles in HNSCC, based on the available evidence, dysregulated snoRNAs are closely associated with the carcinogenesis and development of HNSCC. Upregulated snoRNAs have been shown to augment the expression of other oncogenes or activate the Wnt/β-catenin signaling pathway, thereby promoting tumor cell viability, glycolysis, migration, and the epithelial-mesenchymal transition while inhibiting apoptosis in vitro. In vivo animal studies have further elucidated the functional roles of snoRNAs. Knockdown of host genes of these snoRNAs suppressed the Wnt/β-catenin signaling pathway and restrained tumor proliferation and aggressiveness in mice. The putative mechanisms underlying these observations are associated with the biological functions of snoRNAs, primarily involving microRNA-like functions through the generation of microRNA-like fragments and regulation of alternative splicing to yield diverse transcripts. While most of the snoRNAs are upregulated in HNSCC, 4 downregulated snoRNAs have been identified and annotated. SNORA36B (implicated in the regulation of DNA templates) and U3 (chr17, influencing cell proliferation) may serve as protective factors associated with prolonged overall survival. This review describes the viable structures of snoRNAs, endeavors to refine snoRNA sequencing technology, and summarizes snoRNAs' expression profile as well as their role in HNSCC progression for potential diagnostic and therapeutic strategies for HNSCC management.

Novel Cancer-Promoting Functions and Mechanisms for snoRNAs

SnoRNA and lncSNHG: Advances of nucleolar small RNA host gene transcripts in anti-tumor immunity

SnoRNA in Cancer Progression, Metastasis and Immunotherapy Response

Small but Strong: Pivotal Roles and Potential Applications of Snornas in Hematopoietic Malignancies

Small non-coding RNAs in human cancer: function, clinical utility, and characterization

SnoRNAs: Exploring Their Implication in Human Diseases

Small nucleolar RNA and its potential role in the oncogenesis and development of colorectal cancer

Ott_a_267140 7699..7717

Small Nucleolar RNAs and Their Comprehensive Biological Functions in Hepatocellular Carcinoma

Abstract 3279: Comprehensive Analysis of Small Nucleolar RNAs Across in Human Cancers

A Pan-cancer Analysis of the Expression and Clinical Relevance of Small Nucleolar RNAs in Human Cancer

Disorders and roles of tsRNA, snoRNA, snRNA and piRNA in cancer

The Emerging Role of Snornas in Human Disease

Small Nucleolar RNAs in Head and Neck Squamous Cell Carcinomas

Structure and function of snoRNAs

An Emerging Class of Long Non-coding RNA With Oncogenic Role Arises From the snoRNA Host Genes

Small Nucleolar RNAs as Diagnostic and Prognostic Biomarkers in Cancer: A Systematic Review and Meta-Analysis

Long Noncoding RNA: Its Partners and Their Roles in Cancer

Long Non-Coding Small Nucleolar RNA Host Genes (SNHGs) in Endocrine-Related Cancers

THE RESEARCH PROGRESS OF SMALL NUCLEOLAR RNA AND ITS HOST GENES IN MALIGNANCIES

Role of Long Non-Coding RNAs in Cancer: from Subcellular Localization to Nanoparticle-Mediated Targeted Regulation.